The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2024 | Increasing awareness of germline predispositions to hematological malignancies in pediatric patients
Anupama Rao, MD, Great Ormond Street Hospital, London, UK, highlights the necessity for increasing clinician awareness in regard to the presence of germline predispositions to hematological malignancies, such as acute myeloid leukemia (AML), in pediatric patients. Most hematological predispositions present as common conditions, and a national observational study for pediatric germline predisposition syndromes will aim to make clinicians aware that a proportion of their patients will have these predispositions. Clinicians will be encouraged to reach out to centers of expertise to create well-annotated cohorts of patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Medical Advisory Board: RUNX1 group.
